Article Details
Retrieved on: 2021-01-05 14:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Our treatment strategy deploys specific human monoclonal antibodies to inactivate certain matrix metalloproteinases — MMP-9 and MMP-14 — and ...
Article found on: www.galvnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here